

浏览全部资源
扫码关注微信
Published:2011
移动端阅览
LI Chun-qing, SUN Wei, SHAO Jia-de, et al. Experimental Study on Leizhi Capsule via Reducing Toxity and Increasing Effects of Tripterygium Glucosides in PAN Nephrosis Rats[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(22): 172-177.
目的 :探讨雷至胶囊(雷公藤多苷10 mg·kg-1 + 女贞子、墨旱莲4 g·kg-1)在治疗嘌呤霉素氨基核苷(PAN)肾病的减毒增效作用。 方法 : 80只雄性大鼠随机分为8组:空白组、模型组、雷至胶囊高、低剂量组、雷公藤多苷高、低剂量组、雷公藤甲素组和缬沙坦组
每组10只。颈静脉注射PAN 100 mg·kg-1建立PAN肾病模型。空白组颈静脉注射等量生理盐水。其余各治疗组造模后第2天开始每日分别ig给药
持续10 d。第11天
处死大鼠
摘取肝肾
用于光镜、免疫荧光及透射电镜检测。 结果: 一般情况:模型鼠第5天尿量减少、腹水
而浮肿不明显
体重下降。第7~10天腹水明显
24 h尿蛋白增加
死亡率30%(3/10)。病理改变:模型鼠肾小管上皮细胞变性
电镜下
可见足细胞足突融合、消失
而空白组足细胞结构正常。各药物治疗组24 h尿蛋白、血生化、血红蛋白均有不同程度改善
各治疗组血尿素氮轻度升高(P<0.05)。雷至胶囊及雷公藤多苷10 mg·kg-1组降蛋白尿、改善贫血、降低AST疗效优于其余各组
电镜下
雷至胶囊高剂量组足突融合减轻
足突明显恢复。 结论: 雷至胶囊可能通过降低PAN肾病大鼠蛋白尿、改善贫血、降低AST、减轻足细胞足突融合及肾小管上皮细胞变性等发挥减毒增效作用。
Objective : Toxicity of tripterygium wilfordii often bring damage to digestive system
reproductive system
hematological and immune system
so reducing toxicity but maintaining therapy effect has been focused on tripterygium wilfordii studies in the past decade. Combining with traditional Chinese medicine compounds can reduce the toxicity but maintaining therapy effect of tripterygium. Whether Leizhi capsule (Ligustrum lucidum
Eclipta
plus tripterygium glucosides) can reduce toxity and increase effects of Tripterygium glucosides? So this study aims to explore the effects of Leizhi capsule in puromycin amino nucleoside(PAN) nephrosis rats. Method : Eighty male wistar rats were randomly divided into eight groups
including control group
model group
Leizhi capsule high-dosage and low-dosage group
tripterygium glucosides high-dosage and low-dosage group
triptolid group and valsartan group(with each group ten rats). PAN nephrosis medel was made by jugular vein injection of PAN (100 mg·kg-1)
while control group rats were made by injection of physiological saline with equal volume. By irrigation stomach once a day for ten days
all rats had been given medicines as follows: physiological saline 2 mL for control group and model group
tripterygium glucosides 2 mg dissolved in Erzhi(containing Ligustrum lucidum and Drought Ephraim grass) solusion 1 mL or 1 mg dissolved in Erzhi solusion 0.5 mL for Leizhi capsule high-dosage or low-dose group
tripterygium glucosides 10
5 mg·kg-1 for Tripterygium glucosides high-dosage or low-dose group
triptolid 2 mg·kg-1 for triptolid group and valsartan 7.5 mg·kg-1 for valsartan group. The blood and urine samples were collected
liver and kidney tissues were processed after killed. The glomerular morphology and podocyte ultrastructure were observed respectively. Result : In day 5
model rats were in low spirits
with less urine
ascites
malnutrition and weight loss. From day 7 to day 10
the nephrotic syndromes were worst in model rats
but without skin edema. Some rats died of serious ascites
the mortality is 30%(3/10). Morphologic changes include epithelial cells degenerationrenal tubular and transparent cast
but there are no obvious changes in glomerulus and renal interstitial. Meanwhile
the podocyte processes effacement was obvious in model groups in electronic microscope. The nephrotic syndrome of PAN rats treated with Leizhi capsule and tripterygium glucosides significantly improved
compared with that in PAN model group and other treatment groups. The urinary protein excretion was decreased
plasma albumin was increased
and high cholesterol/triglyceride levels were remission
and anemia improved. Serum creatinine increased mildly(P<0.05). In light microscope
epithelial cells degenerationrenal of renal tubular and transparent cast improved in both leizhi capsule and Tripterygium glucosides samples(P<0.05).Meanwhile
the degree and area of podocte processes effacement was significantly reduced in both leizhi capsule and Tripterygium glucosides groups in electronic microscope(P<0.05). Conclusion : Leizhi capsulecan reduce toxity and increase effects of Tripterygium glucosides by reducing proteinuria
improving anemia
lowering AST
improving podocte processes effacement
and reducing epithelial cells degeneration of renal tubular.
0
Views
2
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621